In this global event, opinion leaders from both the research and patient communities, funders, regulators and representatives from the private sector will participate to collectively advance innovative drug repurposing in Europe and beyond.
Session
Turn of times: From opportunistic discovery to data-driven hypothesis generation in drug repurposing
Date: Wednesday, 6 March 2024
Time: 14:00-15:30
Speakers:
- Massimiliano Gaetani, Head of the Swedish National Unit of Chemical Proteomics, SciLifeLab
- Peter Sjö, Head of Drug Discovery Programme, DNDi
- Matthew Hall, Scientific Director, NCATS
- Anne Carpenter, Institute Scientist, Broad Institute of MIT and Harvard
- Denis Kainov, Professor, Faculty of Medicine and Health Sciences, NTNU
- Brinton Seashore-Ludlow , Team Leader
